about us
AI-Pharma is a hybrid investment platform specifically focused on the AI in Pharma and Drug Discovery sectors, backed by seasoned professionals who have been active in both the investment banking and AI for Drug Discovery industries for years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors, and some of whom made their first investments into the sector in 2014. The fund structures its portfolio based on sophisticated industry intelligence and comparative analytics, which are provided by the Pharma Division of Deep Knowledge Analytics, the world-leading source of market intelligence on the AI for Drug Discovery, Biomarker Discovery and Advanced R&D sectors. Deep Knowledge Analytics uses hundreds of quantitative and fact-based parameters to identify prospective investment targets for the fund by utilising multidimensional analytical frameworks as complex as the industry itself.
AI for Drug Discovery, Biomarker Development and Advanced R&D is considered by the majority of experts and analysts as one of the most prospective sectors in the Pharma industry in terms of its disruptive potential, capability to increase the efficiency and decrease costs of developing new drugs and improve the performance and profitability of leading Pharma corporations
Provides Liquidity Similar to Hedge Funds Combined With Venture Fund Style Objectives
Invests in the Top 10% of Companies in the Longevity Industry
Significantly De-Risks the Interests of Limited Partners and Portfolio
Bets on the Success of the Entire Industry, rather than of Individual Companies
OUR TEAM
DMITRY KAMINSKIY
GENERAL PARTNER
Dmitry Kaminskiy is based in London. He is an experienced AI in Pharma industry investor and entrepreneur and the founder of Deep Knowledge Ventures and Aging Analytics Agency since 2014.
STEFAN HASCOET
MANAGING PARTNER
Stefan Hascoet is based in Geneva. He is a Capital Markets Professional with 15 years of experience in investment products, derivatives and non-recourse lending facilities.
KATE BATZ
MANAGING PARTNER
Kate Batz is based in San Francisco. She is licensed to practice law in California and New York and has 20 years of experience as a Corporate Attorney.
ALEXANDER HOLODNY
HEAD OF UK OPERATIONS
Alexander Holodny is based in London. He is an experienced corporate finance and private equity professional.
IHOR KENDIUKHOV
DEPUTY MANAGING PARTNER
Ihor Kendiukhov is based in Berlin. He is a finance quant, AI and deep tech professional and leads the Big Data and Algorithmic Analytics Departments at Deep Knowledge Group.